These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 29132856)
1. Circumventing iPLEDGE: Circumventing ethical responsibility? Lee KC; Bercovitch L J Am Acad Dermatol; 2017 Dec; 77(6):1185-1187. PubMed ID: 29132856 [No Abstract] [Full Text] [Related]
2. Can we ensure the safe use of known human teratogens?: The iPLEDGE test case. Honein MA; Lindstrom JA; Kweder SL Drug Saf; 2007; 30(1):5-15. PubMed ID: 17194167 [TBL] [Abstract][Full Text] [Related]
4. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero. Lowenstein EB; Lowenstein EJ Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987 [TBL] [Abstract][Full Text] [Related]
5. Does the teratogenicity of isotretinoin outweigh its benefits? Jordan AY; Parks L; Chen SC; Higgins K; Fleischer AB; Feldman SR J Dermatolog Treat; 2005; 16(4):190-2. PubMed ID: 16249139 [No Abstract] [Full Text] [Related]
6. Depression is not common in isotretinoin-treated acne patients. Rohrback JM; Fleischer AB; Krowchuk DP; Feldman SR J Dermatolog Treat; 2004 Jul; 15(4):252. PubMed ID: 15764041 [No Abstract] [Full Text] [Related]
7. Myths of isotretinoin therapy in patients with acne: a personal opinion. Alcalay J J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients. Shah N; Smith E; Kirkorian AY J Am Acad Dermatol; 2021 Dec; 85(6):1597-1599. PubMed ID: 33259877 [No Abstract] [Full Text] [Related]
9. Isotretinoin in Denmark -- 20 years on. Wildfang IL; Nielsen NH; Jemec GB; Ibsen HH; Avnstorp C J Dermatolog Treat; 2002 Sep; 13(3):151-2. PubMed ID: 12227880 [No Abstract] [Full Text] [Related]
10. Use of isotretinoin for acne vulgaris. Merritt B; Burkhart CN; Morrell DS Pediatr Ann; 2009 Jun; 38(6):311-20. PubMed ID: 19588674 [No Abstract] [Full Text] [Related]
11. Eruptive milia during isotretinoin therapy. Farmer W; Cheng K; Marathe K Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619 [TBL] [Abstract][Full Text] [Related]
12. No evidence for increased anxiety in acne patients treated with isotretinoin. Huang YC; Cheng YC J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e344-e345. PubMed ID: 28129485 [No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum associated with isotretinoin therapy. Freiman A; Brassard A J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S107-8. PubMed ID: 17052521 [No Abstract] [Full Text] [Related]
14. Uses and complications of isotretinoin therapy. Ellis CN; Krach KJ J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947 [TBL] [Abstract][Full Text] [Related]
15. Dermatological indications for the use of isotretinoin beyond acne. Forbat E; Ali FR; Al-Niaimi F J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033 [TBL] [Abstract][Full Text] [Related]
16. The moral of the isotretinoin depression story. Feldman SR J Dermatolog Treat; 2004 Jul; 15(4):199. PubMed ID: 15764030 [No Abstract] [Full Text] [Related]
17. [Panic attacks in a patient treated with isotretinoin for acne. Report of one case]. Poblete A C; Herskovic M V; Eva C P Rev Med Chil; 2006 Dec; 134(12):1565-7. PubMed ID: 17277875 [TBL] [Abstract][Full Text] [Related]
18. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease". Mostow EN Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538 [No Abstract] [Full Text] [Related]
19. [How far can we go in diseases that make life difficult: the example of disfiguring dermatoses]. Penso-Assathiany D; Cribier B; Petit A; Wolkenstein P; Consoli S; Ann Dermatol Venereol; 2010 Jan; 137(1):72-7. PubMed ID: 20110076 [No Abstract] [Full Text] [Related]